Last reviewed · How we verify

NCT04393324: Tetrix

The Critical Care Response to the COVID-19 Pandemic in Madrid

Status unknown Last updated 28 May 2020
What this trial tests

trial in COVID-19 in 2,500 participants. Status unknown.

Timeline
24 April 2020
Primary endpoint
31 May 2020
30 June 2020

Quick facts

Lead sponsorHospital San Carlos, Madrid
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment2,500
Start date24 April 2020
Primary completion31 May 2020
Estimated completion30 June 2020
Sites1 location across Spain

Conditions studied

Sponsor

Hospital San Carlos, Madrid

Who can join

Eligibility, any sex, with COVID-19 or ARDS, Human. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Description of the adaptation of ICUs in the region of Madrid to que surge in demand of critical care due to COVID-19

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for COVID-19

Currently open trials in the same condition.

Other Hospital San Carlos, Madrid trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04393324.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing